Plasmablastic Lymphoma: 12 Year Experience From A Single Center In Colombia -South America

Introduction:Plasmablastic lymphoma (PBL) is a rare high-grade lymphoma, in which the cells of origin have overlapping features between B cells and plasma cells. PBL has been associated with immunodeficiency states and Epstein Barr virus co-infection . The incidence of this disease among HIV negative patients is unknown, but the prognosis is poor, with a high relapse rate (60% in the first year of diagnosis) and a 5-year overall survival (OS) rate of less than 30%. Herein, we describe the clinical characteristics and treatment results of PBL patients in a tertiary cancer center in Colombia.